Bio-Rad Laboratories Inc (BIO)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.43 | 1.42 | 1.43 | 1.39 | 1.41 | 1.41 | 1.42 | 1.40 | 1.40 | 1.43 | 1.42 | 1.41 | 1.30 | 1.30 | 1.30 | 1.31 | 1.31 | 1.36 | 1.37 | 1.38 |
Bio-Rad Laboratories Inc demonstrates a strong solvency position based on its solvency ratios. The debt-to-assets ratio, debt-to-capital ratio, and debt-to-equity ratio have consistently been at 0.00 over the past few years, indicating that the company has no significant debt relative to its total assets, capital, or equity.
Furthermore, the financial leverage ratio, which provides insight into the proportion of the company's assets that are funded by debt, has remained relatively stable around the range of 1.30 to 1.43. This indicates that Bio-Rad Laboratories Inc has a conservative capital structure with a low level of financial leverage.
Overall, the solvency ratios suggest that Bio-Rad Laboratories Inc has a healthy financial position with minimal risk associated with debt obligations.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | -46.90 | -19.48 | -35.08 | 23.31 | 15.37 | 8.98 | 8.95 | 9.57 | 12.47 | 17.67 | 34.51 | 104.09 | 332.82 | 98.03 | 47.51 | 28.73 | 19.92 | 13.59 | 11.59 | 11.16 |
The interest coverage ratio of Bio-Rad Laboratories Inc has shown a fluctuating trend over the past few years. Starting from March 31, 2020, at 11.16, the ratio improved steadily throughout 2020 and 2021, reaching a peak of 332.82 on December 31, 2021. This indicates the company's strong ability to cover its interest expenses with its operating income during this period.
However, the interest coverage ratio began to decline from March 31, 2022, until June 30, 2023, indicating a potential reduction in the company's ability to cover its interest obligations. The ratio fell to as low as 8.95 on June 30, 2023, raising concerns about the company's financial health and ability to meet its debt obligations comfortably.
Although there was a slight recovery in the ratio by December 31, 2023, at 15.37, the subsequent quarters of 2024 witnessed significant declines, with negative ratios recorded on June 30, 2024, September 30, 2024, and December 31, 2024. Negative interest coverage ratios indicate that the company's operating income is insufficient to cover its interest expenses, raising red flags about its financial stability and ability to service its debt.
In conclusion, the interest coverage ratio of Bio-Rad Laboratories Inc has exhibited volatility, with periods of strength followed by concerning declines. It is essential for the company to closely monitor and manage its financial leverage and interest expenses to ensure sustainable and healthy financial performance in the future.